Aberrant splicing is a major cause of rare diseases, yet its prediction from genome 13 sequence remains in most cases inconclusive. Recently, RNA sequencing has proven to 14 be an effective complementary avenue to detect aberrant splicing. Here, we developed 15 FRASER, an algorithm to detect aberrant splicing from RNA sequencing data. Unlike 16 existing methods, FRASER captures not only alternative splicing but also intron retention 17 events. This typically doubles the number of detected aberrant events and identified a 18 pathogenic intron retention in MCOLN1. FRASER automatically controls for latent 19 confounders, which are widespread and substantially affect sensitivity. Moreover, 20 FRASER is based on a count distribution and multiple testing correction, reducing the 21 number of calls by two orders of magnitude over commonly applied z score cutoffs, with 1 a minor sensitivity loss. The application to rare disease diagnostics is demonstrated by 2 reprioritizing a pathogenic aberrant exon truncation in TAZ from a published dataset. 3 FRASER is easy to use and freely available. 4
3 because the creation of novel splice sites has a strong pathogenic potential by leading to 1 frameshift, ablation of protein sequences, or creation of non-functional protein sequences. The 2 first method consists of a combination of cutoffs applied to absolute and relative RNA-seq split 3 read counts. 14, 17 The limitation of this method is that statistical significance is not assessed. 4
Furthermore, the cutoffs are not data-driven. In particular, it is unclear whether requiring that an 5 intron occurs in no other sample 14 or in less than 5 affected samples 17 would generalize well to 6 larger cohorts than the ones investigated so far. Kremer et al. 15 instead tested the significance of 7 differential splicing using Leafcutter, 18 a multivariate count fraction model developed for mapping 8 splicing quantitative trait loci. This approach allowed controlling for false discovery rate and was 9 less dependent on cohort size. One limitation, however, was made evident by Frésard et al., 16 10 who showed that strong covariations of split read based splicing metrics are widespread within 11
RNA-seq compendia. The origins of these covariations may include sex, population structure, or 12 technical biases such as batch effects or variable degree of RNA integrity. Not controlling for 13 these latent confounders can substantially affect the sensitivity of detecting aberrant splicing 14 events. To address this issue, Frésard et al. corrected split read based splicing metrics by 15 regressing out principal components. Aberrant splicing events were then identified using a cutoff 16 on z scores (| | ≥ 2) of these corrected splicing metrics. The drawback of this approach is that an 17 absolute z score cutoff does not guarantee any control for false discovery rate. Moreover, a z 18 score cutoff amounts to a quantile cutoff when assuming that the data distribution is approximately 19
Gaussian. However, Gaussian approximations may be inaccurate when splicing metrics are 20 based on low split read counts, which occurs on splice sites with low coverages and at repressed 21 splice sites. 22 Here, we address these issues with FRASER (Find RAre Splicing Events in RNA-seq), an 23 algorithm that provides a count-based statistical test for aberrant splicing detection in RNA-seq 24 samples, while automatically controlling for latent confounders (Figure 1 ). Unlike previous 25 methods, FRASER is not limited to alternative splicing but also captures intron retention events 1 by considering non-split reads overlapping donor and acceptor splice sites. The parameters are 2 optimized for recalling simulated outliers by training a so-called denoising autoencoder. 19 3 FRASER shows substantial improvements against former methods on simulations based on the 4 healthy cohort dataset of the Genotype-Tissue Expression project (GTEx). 20 Lastly, we 5 demonstrate the usage of FRASER for rare disease diagnosis by reanalyzing an RNA-seq dataset 6 of individuals affected by a rare mitochondrial disorder. 15 We modeled those between-sample covariations by fitting a low-dimensional latent space for 12 each tissue separately. The optimal dimension for the latent space was determined by maximizing 13 the area under the precision-recall curve when calling artificially injected aberrant values 14 independently for each splicing metric (denoising autoencoder, Methods). The method was robust 15 to the exact choice of the encoding dimension, as the performance for recalling artificial outliers 16 typically plateaued around the optimal dimension (Supplementary Figure S4A ). The fitted 17 encoding dimension per tissue was 15 for 5 , 16 for 3 , and 12 for in average. Moreover, the 18 fitted encoding dimension approximately grew linearly with the number of samples 19 (Supplementary Figure S4B ). Larger encoding dimensions were typically found for tissues with 20 more samples (Supplementary Figure S4B) . Controlling for the latent space reduced the 21 between-sample correlation from 0.10 +/-0.05 down to 0.02 +/-0.01 (mean +/-standard deviation 22 across tissues, Figure 2D and Supplementary Figure S2D centered logit-transformed 5 for 48 GTEx tissues before (orange) and after (green) correction for the latent 1 space. These plots show that while tissue-specific correlation structures exist among samples, latent space 2 fitting allows correcting for them. 3 Calling aberrant splicing events using the beta-binomial distribution 4 Having established an effective procedure to model between-sample covariations, we then 5 addressed the issue of calling aberrant splicing events by finding statistically significant outlier 6 data points. Based on the latent space, FRASER models the expected value of each observation 7 (Methods). We considered the observations that significantly deviate from their expected value 8 as outliers. To this end, we modeled random deviations from the expected values with the beta-9 binomial distribution, a distribution for count fractions parameterized by its expected count ratio 10 and an intra-class correlation parameter that accounts for variations exceeding sampling noise 11 (Methods). This model allowed computing a two-sided P value for each observation (Methods). 12
For the alternative acceptor splicing metric 5 , the P values of introns with the same donor are 13 not independent since the proportions they are based on sum to one. Therefore, we corrected the 14 5 P values for each donor with the family-wise error rate using Holm's method, which holds 15 under arbitrary dependence assumption (Methods). 26 The same was done for 3 yielding a single 16 P value per acceptor and sample. We additionally controlled the splice site P values for the false 17 discovery rate (FDR) genome-wide per sample using Benjamini-Yekutieli's method (Methods). 27 
18
To showcase the application of FRASER, we used the suprapubic skin tissue from the GTEx 19 dataset as done by Brechtmann et al. 28 Figure 3A shows as an example the 5 metric of the 7 th 20 intron of SRGAP2, which exhibited a proportional relationship between the number of split reads 21 supporting the 7 th intron and the total number of split reads with the same donor site. For this 22 example, the P values tended to be conservative yet modeling reasonably well the distribution of 23 the data across samples ( Figure 3B ). Figure 3C shows as an example with an outlier the 5 metric 24 9 of the 17 th intron of SRRT, with one data point exhibiting a much higher usage of this acceptor 1 site than the other samples and a corresponding very low nominal P value (P = 1.03 x 10 -10 , Figure  2 3D). Across all introns and splice sites, P values were found to be generally conservative ( Figure  3 3E and Supplementary Figure S5 ). An excess of low P values was detected for the most extreme 4 ten thousands of the data, possibly reflecting genuine aberrant splicing events ( Figure 3E ). Similar 5 results were found for all the investigated GTEx tissues (Supplementary Figure S6 
10
Under the null hypothesis, the data is expected to lie along the diagonal (red, 95% confidence bands in We next aimed at assessing the performance of FRASER and delineating the contribution of 2 modeling the covariation on the one hand, and using the beta-binomial distribution on the other 3 hand. Therefore, we simulated a ground truth dataset based on the suprapubic skin tissue in 4 which we artificially injected splicing outliers with a frequency of 10 -3 , which resulted in 25,988, 5 26,153 and 49,169 outliers for 5 , 3 , and , respectively (Methods). The amplitude of the 6 deviations from the original observed values were drawn uniformly between 0.2 and 1 and their 7 directions (increase or decrease) were randomly assigned with equal probability (Methods). We 8 then monitored outlier recall as well as precision, i.e. the proportion of injected outliers among the 9 reported outliers. Methods not modeling covariation performed worse than methods modeling 10 covariation at any level of recall and for all splicing metrics (Figure 4 and Supplementary Figure  11 S7-8). Moreover, methods modeling covariation and using beta-binomial based P values yielded 12 a higher precision than those using z scores (Figure 4 and Supplementary Figure S7 higher precision was observed at all levels of recalls, simulated outlier amplitudes, and read 14 coverage ( Figure 4 ). Notably, using PCA and a z score cutoff equal to 2 instead of FRASER at 15 FDR < 0.1 yielded two orders of magnitude more outliers across all GTEx tissues (Supplementary 16 Figure S9 ) and a drastic drop in precision (3% versus 92% with FRASER) for a small increase in 17 recall (98% versus 83% with FRASER, Supplementary Figure S10 ). This drastic difference of 18 precision strongly suggests using an FDR cutoff rather than an absolute z score cutoff. 19
The benchmark with simulated outliers also allowed investigating alternative ways to estimate the 20 expected values by regression on the latent space. This included a beta-binomial regression, a 21 robust version of the beta-binomial regression, as well as a least squares regression of logit-22 transformed splicing metrics (Methods). The latter approach, which we eventually adopted for 23 FRASER, had similarly high performance as the robust beta-binomial regression (Supplementary 24 Figure S7 -8, Methods) while being much faster to compute. The beta-binomial regression was 25 11 too sensitive to outlier data points and hence was outperformed by its robust version 1 (Supplementary Figure S11 Rare variant enrichment analysis 1 We further evaluated the performance of FRASER by assessing the enrichment of rare genetic 2 variants among splicing outlier genes with the rationale that some aberrant splicing events are 3 caused by rare genetic variants. For this analysis, we defined a variant to be rare when having a 4 minor allele frequency (MAF) less than 0.05 within GTEx 20 and gnomAD 29 as done for gene 5 expression in Li et al. 23 We annotated these variants in two ways. First, we considered splice 6 region variants (Methods), which we defined as variants located within 1-3 bases of an exon or 7 1-8 bases of an intron. This correspond to the union of the splice site dinucleotide and splice 8 region variants as defined by the sequence ontology through the variant effect predictor 9 (VEP). 30, 31 We found on average 299.4 +/-207.6 rare splice region variants. Second, we 10 considered rare variants predicted to affect splicing by MMSplice, 8 affecting splicing may not necessarily be at its closest splice sites. Therefore, we computed the 16 enrichment at the gene level. To this end, we computed gene-level P values using a family wise 17 error rate correction across all splice sites within a gene (Methods). Additionally to the previously 18 benchmarked methods, we also applied the method of Kremer et al., 15 which is based on the 19 gene-level differential splicing algorithm Leafcutter. 18 20 Across all 48 GTEx tissues, FRASER showed higher enrichments than Leafcutter, Gaussian-21 based P values, and non-corrected beta-binomial P values. The higher enrichments observed 22 held for different nominal P value cutoffs and both for rare variants in the splice regions, as well 23 as for those predicted to affect splicing by MMSplice ( Figure 5 and Supplementary Figure S12 ). 24
Notably, the MMSplice variant set showed 2 to 10 times higher enrichments across all methods 25 13 compared to the splice region variant set, emphasizing the importance of considering exonic or 1 deep intronic variants as potential splice-affecting candidates. Altogether, this gene-level 2 benchmark on non-simulated data confirms the importance of controlling for covariation and using 3 a count fraction distribution to identify aberrant splicing. This benchmark also shows that FRASER 4 outperforms both state-of-the-art methods, which are the Leafcutter based approach 15 and the z 5 score based approach. 16 PCA controlled splicing metrics (x-axis). In every panel, the enrichment for each of the 48 GTEx tissues 13 is equal or higher for FRASER (points above the diagonal line). 14 14 Application to rare disease diagnosis 1 Having established FRASER using a large cohort of healthy donors, we next reanalyzed the 119 2 RNA-seq samples from skin fibroblasts of 105 individuals with a suspected rare mitochondrial 3 disorder of Kremer et al. (hereafter the Kremer dataset). 15 In a rare disease diagnosis context, the 4 aim is to identify aberrant splicing events that could be disease causing, typically by disrupting 5 the function of a phenotypically relevant gene. To this end, gene-level statistics are handier entry 6 points than splice-site level statistics. Moreover, we suggest combining statistical significance 7 cutoffs with effect size cutoffs because larger effects are more likely to have strong physiological 8 impacts. For the Kremer dataset, FRASER reported a median of 12, 7, and 10 genes with at least 9 one aberrant splicing event per sample for 5 , 3 , and splicing efficiency, respectively, at a 10 significance level of FDR < 0.1 and an effect size greater than 0.3 (absolute difference between 11 observed and expected value, Figure 6A ). Similar amounts were found on all 48 GTEx tissues 12 (Supplementary Figure S9 ). These criteria yielded slightly less splicing outliers than in the original 13 study (1666 versus 1725, Figure 6B ) yet detecting all novel pathogenic splice events reported in 14 the original study (CLPP, TIMMDC1 in 2 individuals, and MCOLN1, Figure 6B ). Notably, the intron 15 retention event in the gene MCOLN1 was missed by the aberrant splicing pipeline used by Kremer 16 et al. 15 Generally, including the splicing efficiency metrics with FRASER led to a two-fold increase of 19 detected aberrant events over considering the alternative splicing metrics 5 , and 3 alone 20 ( Figure S13 ). Altogether, these findings show the clinical relevance and the complementarity of 21 using both splicing efficiency and alternative splicing metrics. Figure 7A ), which was overlooked in the original study. 15 We implemented FRASER in a modular way so that the procedures for fitting the latent space 19 and for estimating expected values given the latent space can be independently chosen as well 20
as the distributions used to define splicing outliers. The best performing model was obtained using 21 a hybrid combination in which fitting the latent space and estimating expected values are 22 performed with a least-squared loss while the beta-binomial distribution is used for assessing the 1 significance of the outlier. This combination does not correspond to a maximum likelihood fit of a 2 particular distribution we are aware of, but it gave the best empirical results. Future research could 3 investigate whether some other classes of models such as a multivariate logit-normal binomial 4 distribution could provide good maximum likelihood fits to splicing metrics. 5 FRASER is based on splicing metrics defined at the level of individual splice sites. In theory, using 6 a gene model that integrates data across entire splice isoforms can increase sensitivity because 7 all reads supporting an isoform over another contribute to the test statistic. However, the difficulty 8 is that either a gene model must be known beforehand or it has to be assembled de novo. While 9 we were developing FRASER, a preprint described a splicing outlier detection method that fits a 10
Dirichlet-Multinomial distribution at the gene level on all split read counts of alternatively spliced 11 exon-exon junctions called de novo. 24 The method appears to require robust gene models in the 12 first place, because data preprocessing and filters yielded only 6,000 genes analysed on a typical 13 GTEx tissue. This filtering and clustering may be appropriate to investigate healthy populations 14 and basic biology of aberrant splicing, 24 but limits the usability in rare disease diagnostics, where 15 a single event could be the disease-causing one. 16
One limitation of RNA-seq for diagnosis of rare diseases is that the affected tissue may not be 17 accessible. Nonetheless, a causal splicing defect may also be detectable in a clinically accessible 18 tissue such as blood or skin, while its pathological consequence may be revealed only in the 19 affected tissue. The TAZ gene is such an example with pathological effects in heart but with 20 normal gene expression levels in skin despite the splice defect. We suggest investigators to check 21 the gene and exon overlap with tissues of interest, using the MAJIQ-CAT web interface 38 or to 22 refer to the full splice site map of the GTEx tissues we have compiled here (Web Resources). 23
Moreover, this GTEx splice site map can be used to extend RNA-seq compendia for users with 24 only a few samples. In conclusion, through the easy to use R/Bioconductor package and the ability 25 to utilize the preprocessed GTEx dataset, we foresee FRASER to become an important tool for 1 the growing field of RNA-seq based diagnosis of rare diseases. Genotype Tissue Expression Project V7 20 (hereafter the GTEx dataset). Both datasets are not 8 strand-specific. Read mapping files in the BAM file format were obtained for the Kremer dataset 9 by mapping the RNA-Seq reads to the UCSC hg19 genome assembly 39 with the STAR aligner 10 (version 2.4.2a). 40 To detect novel exon junctions, we ran STAR in the two-pass mode (option 11 twopassMode=Basic) with minimal chimeric segment length of 20 (chimSegmentMin=20). For 12
GTEx, we obtained the BAM files from dbGaP (phs000424.v7.p2), which were already aligned 13 with STAR (version 2.4.2a). The GTEx consortia used the same parameters except mapping 14 against the GRCh37 genome assembly based on the GENCODE v19 annotation. 25 We 15 considered only samples with an RNA integrity number of 5.7 or higher and marked as usable by 16
the GTEx consortia (SMRIN and SMAFRZE column, respectively) and discarded tissues with less 17 than 50 samples . 18 Read Counting and splicing metrics 19 The set of acceptor and donor splice sites (or the splice site map) of a dataset was defined by 20 calling all introns including de novo events based on RNA-seq split reads. To this end, the split 21 20 reads were extracted from the BAM files and counted using the R/Bioconductor packages 1 GenomicAlignments and GenomicRanges. 41 Having defined the splice site map, non-split reads 2 overlapping splice sites were counted in order to compute the splicing efficiency, which can be 3 used to detect intron retention. Specifically, the non-split reads were counted for each splice site 4 using the R/Bioconductor Rsubread package 42 requiring at least 5 nt aligned on each side of the 5 splice site to be robust against mapping errors of very short overhangs as done in Braunschweig 6 et al. 43 7 As described by Pervouchin et al., 22 we compute for each sample, for donor D (5' splice site) and 8 acceptor A (3' splice site) the 5 and 3 values, respectively, as: where ( ) is the number of non-split reads spanning exon-intron boundary of donor D, and ( ) 21 is defined as the number of non-split reads spanning intron-exon boundary of acceptor A. While 22 we calculate for the 5' and 3' splice sites separately, we do not distinguish later in the modeling 1 step between 5 and 3 and hence call it jointly . 2
For robust fitting of the model, we restricted the analysis to splice sites of introns supported by at 3 least 20 split reads in at least one sample. Further, we filtered out splice sites and introns where 4 more than 95% of the samples had zero coverage. 5
Statistical Model 6
The metrics 5 , 3 , and are count proportions. For each of these metrics, we model the 7 distribution of the numerator conditioned on the value of the denominator using the beta-binomial 8 distribution. Unlike the binomial distribution, the beta-binomial distribution can account for 9 overdispersion. Specifically, for 5 , we assume that the split read count of the intron = 1, . . . , 10 in sample = 1, . . . , follows a beta-binomial distribution with an intron-specific intra-class 11 correlation parameter and a sample-and intron-specific proportion expectation : where the vectors are the rows of the matrix , the × projection of the data onto the q-3 dimensional latent space with 1 < < ( , ), is the × encoding matrix, the × 4 decoding matrix, and the -vector is a bias term. The input vector ̃ is given by the centered 5 and logit-transformed pseudo-count ratios. We define ̃ as: 6 Fitting of the latent space and the distribution 10 Four parameters must be fitted, namely , the encoding matrix, , the decoding matrix, , the 11 bias term, and , the intra-class correlation of the beta-binomial distribution. The fitting of these 12 parameters is achieved in two steps. First, the latent space and the expected splicing 13
proportions are fitted with a principal component analysis (PCA). To this end, a PCA is 14 computed on the input matrix ̃ using the pcaMethod package. 46 The latent space is then 15 computed with Equation (8) by setting the encoder matrix to the first loadings of the PCA. 16
Given the latent space , is computed by using the transpose of for and setting the 17 bias term to ̅ . In the second step, the intra-class correlation parameter is fitted given the count 18
proportion expectations using a beta-binomial loss function. Specifically, we use the optimize 19 function from R 37 and minimize the average negative beta-binomial log-likelihood in parallel 20 across introns (Supplemental Material and Method). 21 23 Additionally, we implemented an alternative approach to fit the distribution parameters given the 1 latent space . To this end, we use a weighted negative beta-binomial log-likelihood loss function 2 to model in an iterative fashion the decoding matrix and the bias term on the one hand and 3 the intra-class correlation parameter on the other hand. First, we initialize the parameters as 4 described before using PCA. Given the latent space, these parameters can be fitted 5 independently for each intron j. We start by optimizing given the weights and the bias 6 (step 1). Then, we optimize and given in step 2. Steps 1 and 2 are repeated until the 7 average weighted negative log-likelihood of each step in one iteration does not differ more than 8 the convergence threshold of 10 −5 from the last step of the previous iteration, or 15 iterations are 9 reached, which triggers a warning. We use the L-BFGS method implemented in the R function 10 optim to fit the decoder weights and the bias. 47 A detailed derivation of the used loss functions 11 and the respective gradients can be found in the Supplemental Material and Method section . 12 Robust distribution fitting using a weighted log-likelihood 13 Outlier data points can have strong effects on the model fitting. We use weights in the loss function 14 to decrease the influence of outliers on the model, following the edgeR approach. 48 Finding the Hyperparameters 9 The model fitting procedure described above leaves one hyperparameter that remained to be 10 optimized: the latent space dimension . In order to find the optimal latent space dimension , we 11 implemented a denoising autoencoder approach. 19 Specifically, we generated corrupted data by 12 injecting aberrant read count ratios with a frequency of 10 −2 into the original data. The injection 13 scheme is laid out in detail in the next section. We then select as the dimension maximizing the 14 area under the precision-recall curve for identifying corrupted read ratios. This is done for each 15 splicing metric separately. To speed up the fitting procedure of the hyperparamtere, we randomly 16 subset the input matrix ̃ to 15,000 introns out of the 30,000 most variable introns with a mean 17 total coverage greater than 5. This subsetting is done before the injection of aberrant read count 18 ratios. 19
25
Injection of artificial outliers 1 To fit the FRASER hyperparameter as well as to compare the outlier detection performance 2 between FRASER and other methods, we developed a procedure to inject artificial outliers into a 3
given dataset. For injection, we considered all expressed introns or splice sites within the dataset 4 and injected only one outlier per splice site and sample. Outliers were randomly injected with a 5 frequency of 10 −2 for the hyperparameter optimization and with a frequency of 10 −3 for the 6 benchmarking. 7
To create aberrant splicing ratios, we inject in silico a splicing outlier count by changing the 8 original read count such that the value of changes by . is drawn from a uniform 9 distribution: 10 ∼ ± (0.2, ),
(Equation 15) 11
where is the maximal possible for intron in sample . The value of is 12 dependent on the randomly sampled injection direction: = 1 − and = for 13 up-or downregulation, respectively. To ensure that an aberrant splice ratio can be injected the 14 direction is switched if < 0.2. We injected outliers only for introns harboring 10 reads or 15 more in the considered sample. 16
Taking the pseudocounts into account, the outlier count is then given by 17 = round(( ± ) ⋅ ( + 2) − 1).
(Equation 16) 18
In order to provide a biologically realistic outlier injection scheme that preserves the total amount 19 of reads, the counts for the introns sharing the same donor or acceptor, respectively, with 20 are changed accordingly, where the change is distributed equally over all secondary introns 21 as follows: 22 trials follows a beta-binomial distribution with parameters fitted as described above for every 5 pair of sample and intron . We compute two-sided P values using the mean probability of 6 success and the fitted intra-class correlation parameter as follows: 7
The term ½ is included to prevent getting P values greater than 1, which can happen due to the 9 nature of the discrete distributions. 10
The P values of introns sharing a splice site are not independent since the proportions they are 11 based on sum to one. We therefore correct the P values for each splice site with the family-wise 12 error rate (FWER) using Holm's method, which holds under arbitrary dependence assumption, 26 Alternative Splicing Outlier Detection Methods 10 We implemented different alternative splicing outlier detection methods to assess the 11 performance of FRASER. As the baseline for our approach, we used a simple beta-binomial 12 distribution (BB) with no correction for existing covariation and the parameters and were 13 estimated with the R package VGAM. 49 Further, we implemented a Z score approach similar to 14 the approach described by Frésard et al. 16 Instead of regressing out the top principal 15 components accounting for 95% of the variation within the data, we used the top loadings of the 16 PCA maximizing the precision-recall of in silico injected splicing outliers and computed the Z 17 scores according to Equation (16) . Finally, we implemented the Leafcutter 18 approach described 18 by Kremer et al, 15 where one sample is compared against all others within the dataset and no 19 control for latent sources of sample covariation is considered. 20 28 Enrichment analysis 1 For the GTEx enrichment analysis, we obtained all rare variants (MAF < 0.05 within all 635 GTEx 2 samples and in gnomAD 29 ) from the GTEx whole genome sequencing genetic variant data (V7). 3
From this rare variant set, we extracted on the one hand all annotated splicing variants 4 (splice_donor, splice_acceptor, and splice_region) according to the sequencing ontology and 5 VEP. 30, 31 This covers all variants around the exon-intron and intron-exon boundary, which is 1-3 6 bases within the exon and 1-8 bases within the intron. On the other hand, we extracted variants 7 predicted to affect splicing by MMsplice. 8 To this end, we scored all variants within 100 bp of an 8 annotated exon (GENCODE v30) 25 with MMSplice in an exon-centric way. Then, variant-exon 9 pairs with a score of | logit( )| > 2 were selected. We then computed enrichments for rare 10 splicing variants found within outlier genes as the proportion of outliers having a rare splicing 11 variant over the proportion of non-outliers having a rare splicing variant. 12 
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